E. Jabbour, H. Kantarjian, I. Aldoss, P. Montesinos, Jessica T. Leonard, D. Gómez-Almaguer, M. Baer, C. Gambacorti-Passerini, J. Mccloskey, Y. Minami, C. Papayannidis, V. Rocha, P. Rousselot, P. Vachhani, E. Wang, M. Hennessy, Niti Patel, A. Vorog, Bingxia Wang, T. Yeh, Josep-Maria Ribera
{"title":"ALL-300 PhALLCON的第一份报告:一项比较波纳替尼和伊马替尼治疗新诊断的费城染色体阳性急性淋巴细胞白血病的3期研究","authors":"E. Jabbour, H. Kantarjian, I. Aldoss, P. Montesinos, Jessica T. Leonard, D. Gómez-Almaguer, M. Baer, C. Gambacorti-Passerini, J. Mccloskey, Y. Minami, C. Papayannidis, V. Rocha, P. Rousselot, P. Vachhani, E. Wang, M. Hennessy, Niti Patel, A. Vorog, Bingxia Wang, T. Yeh, Josep-Maria Ribera","doi":"10.1016/s2152-2650(23)00946-1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia\",\"authors\":\"E. Jabbour, H. Kantarjian, I. Aldoss, P. Montesinos, Jessica T. Leonard, D. Gómez-Almaguer, M. Baer, C. Gambacorti-Passerini, J. Mccloskey, Y. Minami, C. Papayannidis, V. Rocha, P. Rousselot, P. Vachhani, E. Wang, M. Hennessy, Niti Patel, A. Vorog, Bingxia Wang, T. Yeh, Josep-Maria Ribera\",\"doi\":\"10.1016/s2152-2650(23)00946-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10370,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2152-2650(23)00946-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)00946-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia